ABBVIE INC. (ABBV)
Clinical trial NCT05445778: primary completion date: 2032-05-01 → 2027-04-01.
Clinical trial NCT05445778: primary completion date: 2032-05-01 → 2027-04-01.
Clinical trial NCT06052631: start date: 2026-06-04 → 2026-06-07.
Aeropay Announces Integration with Jack Henry to Strengthen Instant Pay by Bank Infrastructure
Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures
Karyopharm to Present Results from Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis in Late-Breaking Oral Presentation at ASCO 2026 with Simultaneous Publication in the Journal of Clinical Oncology
Clinical trial NCT07291076: enrollment: 129 → 198 participants.
Clinical trial NCT02856893 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-12-01 → 2025-08-12
Clinical trial NCT07166094 updates: 1. completion date: 2029-02-01 → 2029-11-01 2. primary completion date: 2028-11-01 → 2029-08-01 3. enrollment: 544 → 660 participants
Clinical trial NCT05663866: completion date: 2026-07-30 → 2027-03-31.
Clinical trial NCT04346238 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2021-09-30 → 2024-12-01 3. primary completion date: 2021-03-30 → 2024-03-30 4. enrollment type: ESTIMATED → ACTUAL